{"id":"https://openalex.org/W4361235779","doi":"https://doi.org/10.1158/0008-5472.22416515","title":"Supplemental figure legends from Emergence of High-Avidity Melan-A\u2013Specific Clonotypes as a Reflection of Anti\u2013PD-1 Clinical Efficacy","display_name":"Supplemental figure legends from Emergence of High-Avidity Melan-A\u2013Specific Clonotypes as a Reflection of Anti\u2013PD-1 Clinical Efficacy","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361235779","doi":"https://doi.org/10.1158/0008-5472.22416515"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22416515","doi":"https://doi.org/10.1158/0008-5472.22416515","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22416515","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.22416515","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006738419","display_name":"Sylvain Simon","orcid":"https://orcid.org/0000-0001-5985-3946","observed_orcids":["https://orcid.org/0000-0001-5985-3946"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sylvain Simon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033376651","display_name":"Virginie Vignard","orcid":"https://orcid.org/0000-0002-6702-2824","observed_orcids":["https://orcid.org/0000-0002-6702-2824"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Virginie Vignard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045260573","display_name":"\u00c9milie Varey","orcid":"https://orcid.org/0000-0002-3013-2472","observed_orcids":["https://orcid.org/0000-0002-3013-2472"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emilie Varey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016111785","display_name":"Tiphaine Parrot","orcid":"https://orcid.org/0000-0001-9625-6825","observed_orcids":["https://orcid.org/0000-0001-9625-6825"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tiphaine Parrot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019547050","display_name":"Anne\u2010Chantal Knol","orcid":"https://orcid.org/0000-0003-4011-5008","observed_orcids":["https://orcid.org/0000-0003-4011-5008"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne-Chantal Knol","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001247907","display_name":"Amir Khammari","orcid":"https://orcid.org/0000-0001-9328-8004","observed_orcids":["https://orcid.org/0000-0001-9328-8004"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amir Khammari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031244376","display_name":"Nadine Gervois","orcid":"https://orcid.org/0000-0002-0092-3919","observed_orcids":["https://orcid.org/0000-0002-0092-3919"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nadine Gervois","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009482796","display_name":"Fran\u00e7ois Lang","orcid":"https://orcid.org/0000-0002-0762-4647","observed_orcids":["https://orcid.org/0000-0002-0762-4647"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francois Lang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002644565","display_name":"Brigitte Dr\u00e9no","orcid":"https://orcid.org/0000-0001-5574-5825","observed_orcids":["https://orcid.org/0000-0001-5574-5825"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brigitte Dreno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5044083912","display_name":"Nathalie Labarri\u00e8re","orcid":"https://orcid.org/0000-0002-1407-6546","observed_orcids":["https://orcid.org/0000-0002-1407-6546"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nathalie Labarriere","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melan-a","display_name":"Melan-A","score":0.6209999918937683},{"id":"https://openalex.org/keywords/t-cell-clonotypes","display_name":"T cell clonotypes","score":0.7369999885559082},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9190000295639038},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5139999985694885},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6169999837875366},{"id":"https://openalex.org/keywords/tumor-immunology","display_name":"tumor immunology","score":0.5820000171661377},{"id":"https://openalex.org/keywords/tcr-repertoire","display_name":"T cell receptor repertoire","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C179223381","wikidata":"https://www.wikidata.org/wiki/Q419425","display_name":"Avidity","level":3,"score":0.6080664396286011},{"id":"https://openalex.org/C65682993","wikidata":"https://www.wikidata.org/wiki/Q1056451","display_name":"Reflection (computer programming)","level":2,"score":0.5058557391166687},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.34835565090179443},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2881336808204651},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1875247061252594},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.12313660979270935},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22416515","doi":"https://doi.org/10.1158/0008-5472.22416515","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22416515","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22416515.v1","doi":"https://doi.org/10.1158/0008-5472.22416515.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22416515.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22416515","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplemental_figure_legends_from_Emergence_of_High-Avidity_Melan-A_Specific_Clonotypes_as_a_Reflection_of_Anti_PD-1_Clinical_Efficacy/22416515","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22416515","doi":"https://doi.org/10.1158/0008-5472.22416515","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22416515","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361256967","https://openalex.org/W4361256859","https://openalex.org/W4361256849","https://openalex.org/W4361236003","https://openalex.org/W2769385333","https://openalex.org/W4361256788","https://openalex.org/W2257411819"],"abstract_inverted_index":{"Legends":[0],"of":[1],"supplemental":[2],"figures":[3],"S1,":[4],"S2,":[5],"S3":[6],"and":[7],"S4":[8]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-03-31T00:00:00"}